|
Through investigation, a standardization issue in the igf-1 assay was identified.In this specific situation, it has been observed that ig-f measurements for patients presenting igf-1 concentrations in the high measuring range (igf-1 > 800 ng/ml) might lead to increased igf-1 results: the plus bias starts at around igf-1 800 ng/ml and increases progressively up to circa 25% at igf-1 1600 ng/ml.According to good clinical practice, the medical decision attributable to potential igf-1 incorrect test results depends significantly on the constellation of diagnostic and clinical parameters such as the degree of analytical variation of affected results, specific affected range, detectability by technical indices, detectability due to clinical implausibility, additional diagnostic testing results and congruence of the overall clinical picture.Thus, both the igf-1 values (obtained increased igf-1 and true igf-1) are clearly above the upper end of the normal range for igf-1 expected values.Together, in the potential clinical scenarios, it is unlikely that clinical care could be significantly influenced by the observed issue.
|